HILLEVAX INC's ticker is and the CUSIP is 43157M102. A total of 69 filers reported holding HILLEVAX INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $83,000 | +50.9% | 5,697 | +71.5% | 0.00% | – |
| Q1 2024 | $55,000 | -71.8% | 3,322 | -72.5% | 0.00% | – |
| Q4 2023 | $195,000 | +119.1% | 12,092 | +84.1% | 0.00% | – |
| Q3 2023 | $89,000 | +8.5% | 6,568 | +37.4% | 0.00% | – |
| Q2 2023 | $82,000 | +34.4% | 4,779 | +28.9% | 0.00% | – |
| Q1 2023 | $61,000 | -29.9% | 3,707 | -28.1% | 0.00% | – |
| Q4 2022 | $87,000 | +2800.0% | 5,158 | +3164.6% | 0.00% | – |
| Q3 2022 | $3,000 | +200.0% | 158 | +116.4% | 0.00% | – |
| Q2 2022 | $1,000 | – | 73 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 9,285,682 | $101,493,000 | 9.58% |
| Qiming U.S. Ventures Management, LLC | 558,923 | $6,109,000 | 8.48% |
| Abingworth LLP | 1,838,486 | $19,929,000 | 6.38% |
| Samsara BioCapital, LLC | 762,577 | $8,335,000 | 2.22% |
| SEVEN GRAND MANAGERS, LLC | 34,386 | $376,000 | 0.85% |
| StepStone Group LP | 676,567 | $7,395,000 | 0.79% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,617,948 | $28,614,000 | 0.59% |
| RA Capital Management | 1,760,019 | $19,237,000 | 0.51% |
| Perceptive Advisors | 764,907 | $8,360,000 | 0.26% |
| BVF INC/IL | 382,513 | $4,181,000 | 0.20% |